| 注册
首页|期刊导航|中国药理学通报|M3受体亚型在NSCLC细胞增殖、侵袭和迁移中的作用及机制研究

M3受体亚型在NSCLC细胞增殖、侵袭和迁移中的作用及机制研究

王士奇 魏晓莉 闫海涛

中国药理学通报2017,Vol.33Issue(12):1661-1668,8.
中国药理学通报2017,Vol.33Issue(12):1661-1668,8.DOI:10.3969/j.issn.1001-1978.2017.12.008

M3受体亚型在NSCLC细胞增殖、侵袭和迁移中的作用及机制研究

Studies on proliferation and migration effects and mechanisms of M3 mAChR in NSCLC cells

王士奇 1魏晓莉 1闫海涛1

作者信息

  • 1. 军事医学科学院毒物药物研究所,北京 100850
  • 折叠

摘要

Abstract

Aim To investigate the effect of M3 mAChR on the proliferation and migration of NSCLC and the molecular mechanisms. Methods CCK-8 as-say,Wound-healing assay and Transwell invasion as-saywere used to determine the cell proliferation,migra-tion and invasion. Calcium imaging was used to identi-fy the M3 mAChR subtype mediating carbachol-in-duced increase in intracellular calcium. Western blot was used to determine the protein level of proliferation, migration and cell cycle related signaling molecules. Results Following the treatment with M3R antagonists 1. 25 ~ 80 μmol · L - 1 for 48 h,the proliferation of NSCLC cells was inhibited,the inhibitory effect:R2-8018 > Darifenacin,H1299 > H460. After the treat-ment with R2-8018,the migration and invasion of H1299 significantly declined. Western blot showed that the protein level of p-Akt,p-GSK3β,cyclinD1 de-clined significantly with the increase of time and that the protein level of p21 increased. Conclusion M3R antagonists induce cell cycle arrest by suppressing the activation of Akt,down-regulating GSK3β and cy-clinD1,and up-regulating p21,then inhibiting the proliferation of NSCLC cells. It also inhibits the inva-sion and migration by down-regulating MMP-2.

关键词

非小细胞肺癌/M3受体/增殖/侵袭/迁移/基质金属蛋白酶2

Key words

non-small cell lung cancer/M3 muscarin-ic receptor/proliferation/invasion/migration/matrix metal proteinases

分类

医药卫生

引用本文复制引用

王士奇,魏晓莉,闫海涛..M3受体亚型在NSCLC细胞增殖、侵袭和迁移中的作用及机制研究[J].中国药理学通报,2017,33(12):1661-1668,8.

基金项目

国家自然科学基金资助项目(No 81472187) (No 81472187)

中国药理学通报

OA北大核心CSCDCSTPCD

1001-1978

访问量0
|
下载量0
段落导航相关论文